Open AccessPotential digenic inheritance of familial hypertrophic cardiomyopathy identified by whole‐exome sequencing
Author(s) -
Ren MingBao,
Chai XiaoRui,
Li Lin,
Wang Xin,
Yin Chenghong
Publication year - 2020
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.1150
Subject(s) - myh7 , sanger sequencing , hypertrophic cardiomyopathy , exome sequencing , genetics , exome , in silico , genetic testing , gene , medicine , biology , mutation , cardiology , gene isoform
Background The aim of this study was to identify the genetic causes of patients with hypertrophic cardiomyopathy (HCM) within a family. Most of the previous studies found point mutations as the genetic causes for HCM, whole‐gene deletion was rarely reported. Methods Although, clinical genetic testing has been widely used for identifying variants in HCM patients, structural variations are understudied, partly owing to the inadequacy of the available methodology. In the present study, whole‐exome sequencing (WES) and Sanger sequencing validation was used to identify the genetic causes in patients with familial HCM. Results A genomic deletion in Chromosome 19 containing the whole of troponin I3 gene ( TNNI3 ), and the p.Ile736Thr variant in the myosin heavy chain 7 gene ( MYH7 ) were identified in two patients with familial HCM by WES. The p.Ile736Thr variant is further validated by Sanger sequencing and is predicted as a pathogenic variant by in silico analysis. Conclusion We added the notion that not only p.Ile736Thr variant of MYH7 , but also TNNI3 deletion might potentially contribute to HCM pathogenesis. Our study also suggested WES was a powerful tool to identify the genetic variants causing HCM.